Immunogenicity after the first dose of the BNT162b2 mRNA Covid-19 vaccine: real-world evidence from Greek healthcare workers

Kontopoulou, Konstantina; Ainatzoglou, Alexandra; Ifantidou, Athina; Nakas, Christos T.; Gkounti, Georgia; Adamopoulos, Vasilios; Papadopoulos, Nikitas; Papazisis, Georgios (2021). Immunogenicity after the first dose of the BNT162b2 mRNA Covid-19 vaccine: real-world evidence from Greek healthcare workers. Journal of medical microbiology, 70(8) SGM 10.1099/jmm.0.001387

[img]
Preview
Text
Immunogeneicity.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC).

Download (346kB) | Preview

Real-world data regarding the effectiveness, safety and immunogenicity of the Pfizer-BioNTech BNT162b2 mRNA vaccine are accumulating in the literature, suggesting that this vaccine generates high titres of S1-binding IgG antibodies that exhibit potent virus neutralization capacity. This is the first phase IV immunogenicity study to recruit a large number of Greek healthcare workers (n=425) including 63 previously-infected subjects. We measured titres of neutralizing IgGs against the receptor-binding domain of the S1 subunit of the spike protein of SARS-CoV-2 14 days post-immunization with the first dose, employing the SARS-CoV-2 IgG II Quant assay. A total of 92.24 % of our study cohort received a positive assay outcome and titres varied with age. Post-hoc analysis revealed that although titres did not significantly differ among participants aged 20-49 years, a significant decline was marked in the age group of 50-59 years, which was further accentuated in subjects aged over 60. Antibody titres escalated significantly among the previously-infected, indicating the potential booster effect of the first dose in that group.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Institute of Clinical Chemistry

UniBE Contributor:

Nakas, Christos T.

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0022-2615

Publisher:

SGM

Language:

English

Submitter:

Karin Balmer

Date Deposited:

12 Jan 2022 15:31

Last Modified:

05 Dec 2022 15:56

Publisher DOI:

10.1099/jmm.0.001387

PubMed ID:

34397348

BORIS DOI:

10.48350/162275

URI:

https://boris.unibe.ch/id/eprint/162275

Actions (login required)

Edit item Edit item
Provide Feedback